SA
Log In
WBA
OverviewIntelligenceChart
Signal
Bullish Setup2↑
Price
1→
Move→+0.50%Quiet session
Volume
1↑
Volume↑26.7× avgSurge — unusual activity
Technical
1↑
RSI↑RSI 58Momentum positive
PRICE
Prev Close
11.92
Open
11.98
Day Range—
52W Range8.08 – 13.25
8.08
13.25
75% of range
VOLUME & SIZE
Avg Volume
16.9M
FUNDAMENTALS
P/E Ratio
-1.6x
Not profitable
EPS (TTM)
—
Div Yield
0.05%
Beta
0.76
Low vol
Quick Read
Trend—Insufficient MA data
Momentum
NEUTRAL
rev +6% · 17% gross margin
Valuation
FAIR
P/E not available
Health
WEAK
CR 0.6 (low) · FCF negative
Lean Bearish
Key MetricsTTM
Market Cap$10.37B
Revenue TTM$154.58B
Net Income TTM-$6.30B
Free Cash Flow$580.00M
Gross Margin17.3%
Net Margin-2.8%
Operating Margin-1.8%
Return on Equity-38.8%
Return on Assets-4.7%
Debt / Equity4.04
Current Ratio0.60
EPS TTM$-3.81
Alpha SignalsView Intelligence →

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
6 concern
4/100
Liquidity
0.60Concern
Leverage
4.04Concern
Coverage
-5.7xConcern
ROE
-38.8%Concern
ROIC
-4.6%Concern
Cash
$1.3BConcern
ANALYST COVERAGE22 analysts
HOLD
▲ +8.5%upside to target
L $9.00
Med $13.00consensus
H $57.00
Buy
418%
Hold
1255%
Sell
627%
4 Buy (18%)12 Hold (55%)6 Sell (27%)
Full report →
Stock Health
Composite Score
2 of 4 signals bullish
6/10
Technicals
●
RSI RangeRSI 58 — Bullish momentum
✓
Fundamentals
●
Last EarningsBeat estimates
✓
●
Analyst ConsensusHold
~
●
LiquidityCurrent Ratio 0.60 — liquidity risk
✗

1 signal unavailable — limited data for this stock

Upcoming Events
EEarnings ReportMay 1, 2026
Tomorrow
DEx-Dividend DateJul 29, 2026
In 90 days
PDividend PaymentJul 31, 2026
In 92 days
Research
Fundamentals→Financials→Analysts→Earnings→Growth→Key Metrics→Technical Analysis→Intelligence→
Technicals
Technical SetupBULLISH
Technicals →

Trend

▲ UptrendGolden Cross · 50D leads 200D by 16.7%

+0.5% vs SMA 50 · +17.3% vs SMA 200

Momentum

RSI58.0
Positive momentum, not extended
MACD+0.00
Above zero — bullish momentum · compressing
Market Position
Price Levels
52W High
$13.25+10.6%
Current
$11.98
EMA 50
$11.91-0.6%
EMA 200
$10.21-14.7%
52W Low
$8.08-32.6%
52-Week RangeNear 52-week high
$8.0875th %ile$13.25
Earnings & Analysts

ANALYST ESTIMATES

Consensus of 13 analysts
Full estimates →
Analyst revisions:EPS↑ Revised UpRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2024
$145.8B
$144.5B–$146.4B
—$2.85—
±2%
High13
FY2025
$154.5B
$151.8B–$157.9B
▲ +6.0%$1.77▼ -37.8%
±5%
High7
FY2026(current)
$156.0B
$146.9B–$162.1B
▲ +1.0%$1.57▼ -11.5%
±19%
High7
Range confidence:Tight (high)ModerateWide (low)
🔥Beat 5 consecutive quarters
Earnings HistoryWBA
Last 8Q
+21.1%avg beat
Beat 7 of 8 quartersMissed 1↓ Estimates falling
+5%
Q1'24
+47%
Q1'24
-7%
Q2'24
+9%
Q4'24
+38%
Q1'25
+18%
Q2'25
+16%
Q2'25
+44%
Q4'25
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
No recent activity
Deutsche BankHold
Mar 7
UPGRADE
Deutsche BankHold → Sell
Feb 28
DOWNGRADE
BarclaysEqual-Weight → Overweight
Oct 23
UPGRADE
Cowen & Co.Outperform
Nov 22
UPGRADE
Deutsche BankHold → Buy
Nov 11
UPGRADE
Insider Activity
SEC Filings →
1 Buy/1 SellNeutral
Pessina StefanoDir
$9.2M
Apr 27
BUY
Pessina StefanoDir
$9.2M
Apr 27
SELL
Financials
Dividends2.09% yield
2 yrs of payments
Annual Yield2.09%
Quarterly Div.$0.2500
Est. Annual / Share$1.00
FrequencyQuarterly
Q1'23
Q2'23
Q3'23
Q4'23
Q1'24
Q2'24
Q3'24
Q4'24

Dividend per payment — last 8 periods

INSTITUTIONAL OWNERSHIP

13-F Filings →
1
Glenmede Investment Management, LP
0▼
2
SHELL ASSET MANAGEMENT CO
0▼
3
FSA Wealth Management LLC
0▼
4
Gitterman Wealth Management, LLC
0▼
5
WETHERBY ASSET MANAGEMENT INC
0▼
6
Hemington Wealth Management
0▼
7
WNY Asset Management, LLC
0▼
8
PITCAIRN CO
0▼
News & Activity

WBA News

20 articles · 4h ago

About

walgreens boots alliance is the first global pharmacy-led, health and wellbeing enterprise. the company was created through the combination of walgreens and alliance boots in december 2014, bringing together two leading companies with iconic brands, complementary geographic footprints, shared values and a heritage of trusted health care services through pharmaceutical wholesaling and community pharmacy care, dating back more than 100 years. the company employs more than 370,000* people and has a presence in more than 25* countries; it is the largest retail pharmacy, health and daily living destination in the usa and europe. including its equity method investments, walgreens boots alliance is a global leader in pharmacy-led, health and wellbeing retail with over 13,100* stores in 11* countries. the company includes one of the largest global pharmaceutical wholesale and distribution networks with over 350* distribution centers delivering to more than 200,000** pharmacies, doctors, he

CEO
Stefano Pessina
Country
United States
Website
walgreensbootsalliance.com ↗
Neal Joseph SampleExecutive Vice President & Chief Information Officer
Manmohan MahajanExecutive Vice President & Global Chief Financial Officer
Matthew D'AmbrosioSenior Vice President and Global Chief Compliance & Ethics Officer

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance